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All enzyme-encoding pET28a-based expression plasmids were purchased from BioCat GmbH. The 
expression strain E. coli Δmtn (DE3) was constructed in previous study in our lab.1 Proteins were 
analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) under denaturing 
conditions. The gels were stained with Coomassie brilliant blue.  
High resolution electron spray ionization mass spectroscopy (HRESIMS) spectra were obtained on a 
Bruker maXis 4G UHR-TOF Mass Spectrometer. 1H NMR spectra were recorded on a Bruker Avance 
Neo NMR spectrometer operating at 500 MHz proton frequency and chemical shifts were internally 
referenced to residual proton signals of solvents. Chemical shifts (δ) were reported in parts per million 
(ppm). Standard abbreviations indicating multiplicity were used as follows: s (singlet), d (doublet), t 
(triplet), and m (multiplet). Coupling constants (J) were reported in Hertz (Hz). 
Unless otherwise noted, all chemicals and reagents were purchased from Sigma Aldrich and used 
without further purification. Antibiotics were purchased from PanReac AppliChem. Ingredients for 
buffers were purchased from Acros Organics. Substrates and authentic compounds were purchased from 
Fluchem, Alfa Aesar or Acros Organics. L-2-amino-5-methyl hexenoic acid was from Activate 
Scientific. Deuterated solvents were purchased from Cambridge Isotope Laboratories.  
Protein	expression		
E. coli Δmtn (DE3) cells were transformed with pET28a expression plasmids by electroporation. 
Transformed cells were first cultivated on solid medium (LB-AGAR plates with 50 µg/ml kanamycin) 
and then in liquid medium. After incubation at 37°C overnight, 15 ml of pre-culture was used to 
inoculate fresh Terrific Broth (TB) medium (1L) with kanamycin (50 µg/ml). The cells were grown in 
3L shaking flask at 37 °C (170 rpm) until OD600 reached 1.0. The culture was cooled to 20 °C 
supplemented with 0.1 mM isopropyl β-D-thiogalactoside (IPTG). This culture was incubated at 20 °C 
for 24 hours. Cells were harvested by centrifugation at 10,000 x g for 30 minutes and stored at -20 °C. 
For purification, cell pellets (10 g) were suspended in 40 ml lysis buffer (50 mM sodium phosphate, 300 
mM NaCl, 10 mM imidazole, pH 8.0). Cells were disrupted by sonication for 3 x 60 s with Branson 
sonifier 450 (output control 5, 50% duty cycle). Lysates were centrifuged at 10,000 x g for 1.0 h at 4 
°C. The cleared lysate was mixed with 1 ml of NiII NTA agarose at 4 °C for 20 min and loaded onto a 
column. The agarose beads were washed with 10 ml lysis buffer containing 10 mM and 20 mM 
imidazole respectively. The protein was eluted in a lysis buffer solution containing 250 mM imidazole. 
Protein containing fractions were collected and dialyzed against dialysis buffer (100 mM sodium 








































L-amino acids: 1 ml reactions containing 2 mM of substrate, 4 mM methyl iodide, 40 µM SAH, 40 µM 
PLP, 40 µM IlvE, 40 µM a-keto acid C-methyltranferase, 20 µM HMT and 100 mM sodium phosphate 
buffer (pH = 8.0) were incubated at room temperature. After 24 hours, the reaction was quenched by 
addition of 500 µl of CHCl3 and vigorous mixing on the vortex. The aqueous layer was isolated by 
centrifugation and lyophilized. After lyophilization, the mixture was dissolved in 600 µl of D2O. 1H 
NMR was recorded. Conversion efficiency (% of consumed amino acid) and ratio of different product 
were determined by integration of characteristic 1H NMR resonances from different compounds 
(Supplementary Figure 3-23) 
D-amino acids: 1 ml reactions containing 2 mM of substrate, 4 mM methyl iodide, 40 µM SAH, 80 µM 
PLP, 80 µM D-TA, 40 µM a-keto acid C-methyltranferase, 20 µM HMT and 100 mM sodium phosphate 
buffer (pH = 8.0) were incubated at room temperature. Work-up and analysis of these reactions was 






For the structural characterization of products 3 ml reactions were incubated for 24 – 72 h, lyophilized, 
dissolved in D2O and analyzed by 1H NMR, 13C NMR and HRESIMS. Comparison of enzymatically 
produced L-allo-isoleucine (11) and D-isoleucine (28) with authentic material established their 
absolute stereochemistry.  
 
L-allo-isoleucine (2) from L-norvaline (1)  
HRESIMS C6H14NO2 (M+H)+ calcd. 132.1019, obsvd. 132.1018. 
1H NMR (500 MHz, D2O, pD 8) δ = 3.73 (d, J = 3.6 Hz, 1H), 2.03-2.08 (m, 1H), 1.39-1.46 (m, 1H), 
1.30-1.36 (m, 1H), 0.95 (t, J = 7.3 Hz, 3H), 0.93 (d, J = 7.0 Hz, 3H). 
Authentic L-allo-isoleucine, 1H NMR (500 MHz, D2O, pD 8) δ 3.74 (d, J = 3.6 Hz, 1H), 2.05 – 2.10 
(m, 1H), 1.43 (dq, J = 14.2, 7.2 Hz, 1H), 1.35 (dq, J = 14.2, 7.2 Hz, 1H), 0.97 (t, J = 7.4 Hz, 3H), 0.94 
(d, J = 7.2 Hz, 3H). 
 
12 from L-leucine (2) 
HRESIMS C7H16NO2 (M+H)+ calcd. 146.1176, obsvd. 146.1177. 
1H NMR (500 MHz, D2O, pD 8): δ = 3.80 (d, J = 3.8 Hz, 1H), 1.78~1.85 (m, 1H), 1.51~1.58 (m, 1H), 
0.99 (d, J = 6.8 Hz, 3H), 0.96 (d, J = 6.5 Hz, 3H), 0.90 (d, J = 7.0 Hz, 3H).  
13C NMR (126 MHz, D2O, pD 8) δ =  176.6 (assigned by 2D NMR), 57.5, 40.9, 29.3, 20.3, 19.4, 10.9. 
 
13 from L-norleucine (3) 
HRESIMS C7H16NO2 (M+H)+ calcd. 146.1176, obsvd. 146.1177. 
1H NMR (500 MHz, D2O, pD 8): δ =  3.72 (d, J = 3.6 Hz, 1H), 2.17-2.22 (m. 1H), 1.28-1.43 (m, 4H), 
0.92 (d, J = 7.0 Hz, 3H), 0.91 (t, J = 7.0 Hz, 3H).  





14 from L-allylglycine (4) 
HRESIMS C6H12NO2 (M+H)+ calcd. 130.0863, obsvd. 130.0861. 
1H NMR (500 MHz, D2O, pD 8): δ =  5.86 (ddd, J = 6.6, 10.6, 17.0 Hz, 1H), 5.28 (d J = 10.6 Hz 1H), 
5.27 (d, J = 17.0 Hz, 1H), 3.78 (d, J = 4.0 Hz,1H), 2.87-2.93 (m, 1H), 1.11 (d, J = 7.1 Hz, 1H). 
13C NMR (126 MHz, D2O, pD 8) δ =  173.4 (assigned by 2D NMR), 137.6, 117.5, 58.4, 37.8, 13.0. 
 
15 from L-4,5-dehydroleucine (5). SgvM concentration was 80 µM in this cascade. 
HRESIMS C7H12NO2 (M-H)-, calcd. 142.0874, obsvd. 142.0876. 
1H NMR (500 MHz, D2O, pD 8) δ =  5.07 (s, 1H), 4.93 (s, 1H), 3.88 (d, J = 4.1 Hz, 1H), 2.81-2.86 
(m, 1H), 1.81 (s, 3H), 1.07 (d, J = 7.2 Hz, 3H). 
13C NMR (126 MHz, D2O, pD 8) δ =  174.1 (assigned by 2D NMR), 144.0 (assigned by 2D NMR), 
113.4 (assigned by 2D NMR), 56.2 (assigned by 2D NMR), 40.4, 20.6, 11.8. 
 
16 from L-2-amino-5-methyl hexanoic acid (6) 
HRESIMS C8H16NO2 (M-H)-, calcd. 158.1187, obsvd. 158.1186. 
1H NMR (500 MHz, D2O, pD 8): δ =  3.65 (d, J = 3.6 Hz, 1H), 2.22-2.27 (m. 1H), 1.59-1.67 (m. 1H), 
1.20 (t, J = 7.4 Hz, 2H), 0.90 (d, J = 7.0 Hz, 3H), 0.89 (d, J = 7.0 Hz, 3H), 0.86 (d, J = 6.6 Hz, 3H), 
13C NMR (126 MHz, D2O, pD 8) δ =  174.7 (assigned by 2D NMR), 59.1, 41.5, 31.3, 24.4, 22.2, 21.1, 
13.6. 
 
17 from L-2-amino-5-methyl Hex-4-enoic acid (7) 
HRESIMS C8H14NO2 (M-H)-, calcd. 156.1030, obsvd. 156.1029. 
1H NMR (500 MHz, D2O, pD 8) δ =  4.96 (d, J = 9.7 Hz, 1H), 3.59 (d, J = 4.8 Hz, 1H), 2.96-3.01 (m, 







13C NMR (126 MHz, D2O, pD 8) δ =  173.6 (assigned by 2D NMR), 136.8, 123.0, 59.23, 33.2, 25.0, 
17.3, 15.8. 
 
18 from L-methionine (8). SgvM, PLP and IlvE concentration was 80 µM in this cascade. 
HRESIMS C6H14NO2S (M+H)+, calcd. 164.0740, obsvd. 164.0739. 
1H NMR (500 MHz, D2O, pD 8) δ =  3.91 (d, J = 3.3 Hz, 1H), 2.58 (d, J = , 3.0 Hz, 1H), 2.57 (d, J = , 
3.1 Hz, 1H), 2.38-2.43 (m, 1H), 2.11 (s, 3H), 1.01 (d, J = 7.1 Hz, 3H). 
13C NMR (126 MHz, D2O, pD 8) δ =  174.3 (assigned by 2D NMR), 57.4, 36.5, 33.2, 14.3, 13.6. 
 
19 from L-cyclopropyl alanine (9). 
HRESIMS C7H12NO2 (M-H)-, calcd. 142.0874, obsvd. 142.0876. 
1H NMR (500 MHz, D2O, pD 8) δ =  3.78 (d, J = 4.0 Hz, 1H), 1.33–1.44 (m, 1H), 1.03 (d, J = 7.1 Hz, 
3H), 0.64-0.72 (m, 1H), 0.56-0.62 (m, 1H), 0.50-0.55 (m, 1H), 0.20-0.28 (m, 2H). 
13C NMR (126 MHz, D2O, pD 8) δ =  174.4 (assigned by 2D NMR), 59.6, 39.3, 13.7, 13.6, 3.8, 3.5. 
 
20 from L-tryptophan (10). MarG and MarI were used for this cascade. 1H NMR is consistent with that 
from literature.2 
1H NMR (500 MHz, D2O, pD 8): δ =  7.79 (d, J = 7.9 Hz, 1H), 7.56 (d, J = 8.2 Hz, 1H), 7.34 (brs, 1H), 
7.29 (d, J = 7.2, 8.2 Hz, 1H), 7.21 (d, J = 7.2, 7.9 Hz, 1H), 4.16 (d, J = 4.0 Hz, 1H), 3.95 (m, 1H), 1.41 
(d, J = 7.3 Hz, 3H). 
 
28 from D-norvaline (21). 
1H NMR (500 MHz, D2O, pD 8) δ =  3.64 (d, J = 4.0 Hz, 1H), 1.93 - 1.98 (m, 1H), 1.42 - 1.47 (m, 
1H), 1.21 - 1.28 (m, 1H), 0.99 (d, J = 7.0 Hz, 3H), 0.91 (t, J = 7.4 Hz, 3H). 
Authentic D-isoleucine. 1H NMR (500 MHz, D2O, pD 8) δ =  3.66 (d, J = 4.0 Hz, 1H), 1.95 – 2.01 




29 from D-leucine (22). 
HRESIMS C7H15NNaO2 (M+Na)+, calcd. 168.0995, obsvd. 168.0995. 
1H NMR (500 MHz, D2O, pD 8) δ =  3.68 (d, J = 5.4 Hz, 1H), 1.73 - 1.79 (m, 1H), 1.63 - 1.73 (m, 
1H), 0.98 (d, J = 6.6 Hz, 3H), 0.90 (d, J = 6.9 Hz, 3H), 0.86 (d, J = 6.7 Hz, 3H). 
13C NMR (126 MHz, D2O, pD 8) δ =  174.5 (assigned by 2D NMR), 58.0, 40.8, 28.3, 20.7, 17.7, 16.8, 
11.2. 
 
30 from D-norleucine (23). 
HRESIMS C7H16NO2 (M+H)+, calcd. 146.1176, obsvd. 146.1173. 
1H NMR (500 MHz, D2O, pD 8) δ =  3.64 (d, J = 3.8 Hz, 1H), 2.06 - 2.14 (m, 1H), 1.17 – 1.51 (m, 4H), 
0.99 (d, J = 7.0 Hz, 3H), 0.86 (t, J = 7.1 Hz, 3H).  
13C NMR (126 MHz, D2O, pD 8) δ =  174.3 (assigned by 2D NMR), 59.4 (assigned by 2D NMR), 
33.47, 33.35, 19.63, 15.04, 13.14. 
 
31 from D-allylglycine (24). 
HRESIMS C6H12NO2 (M+H)+, calcd. 130.0863, obsvd. 130.0863. 
1H NMR (500 MHz, D2O, pD 8.0) δ =  5.75 (ddd, J = 17.5, 10.4, 7.3 Hz, 1H), 5.24 (d, J = 17.4 Hz, 1H), 
5.23 (d, J = 10.4 Hz, 1H), 3.61 (d, J = 5.6 Hz, 1H), 2.76-2.83 (m, 1H), 1.14 (d, J = 7.1 Hz, 3H).  
13C NMR (126 MHz, D2O, pD 8) δ =  173.8 (assigned by 2D NMR), 136.75, 118.13, 59.13, 38.40, 
15.30. 
 
32 from D-2-amino-5-methyl hexanoic acid (25).  
HRESIMS C8H18NO2 (M+H)+, calcd. 160.1332, obsvd. 160.1330. 
10 
 
1H NMR (500 MHz, D2O, pD 8): δ =  3.65 (d, J = 3.6 Hz, 1H), 2.16-2.21 (m, 1H), 1.61 - 1.69 (m, 1H), 
1.17 - 1.23 (m, 1H), 1.10-1.16 (m, 1H), 1.00 (d, J = 7.0 Hz, 3H), 0.89 (d, J = 6.6 Hz, 3H), 0.83 (d, J = 
6.5 Hz, 3H).  
13C NMR (126 MHz, D2O, pD 8) δ =  174.1 (assigned by 2D NMR), 60.03, 40.23, 31.63, 24.45, 22.87, 
20.57, 15.26. 
 
33 from D-methionine (26). 
HRESIMS C6H14NO2S (M+H)+, calcd. 164.0740, obsvd. 164.0736. 
1H NMR (500 MHz, D2O, pD 8.0) δ =  3.85 (d, J = 3.6 Hz, 1H), 2.71 (dd, J = 13.4, 6.4 Hz, 1H), 2.53 
(dd, J = 13.4, 8.0 Hz, 1H), 2.24 - 2.29 (m, 1H), 2.10 (s, 3H), 1.07 (d, J = 7.0 Hz, 3H). 
13C NMR (126 MHz, D2O, pD 8) δ =  173.3 (assigned by 2D NMR), 58.1 (assigned by 2D NMR), 
36.66, 33.8, 14.6, 14.4. 
 
34 from D-cyclopropyalanine (27). 
HRESIMS C7H13NNaO2 (M+Na)+, calcd. 166.0838, obsvd. 166.0838. 
1H NMR (500 MHz, D2O, pD 8.0) δ =  3.67 (d, J = 4.7 Hz, 1H), 1.29 - 1.35 (m, 1H), 1.09 (d, J = 7.1 
Hz, 3H), 0.65 - 0.71 (m, 1H), 0.46 - 0.53 (m, 2H), 0.22 - 0.26 (m, 1H), 0.10 - 0.14 (m, 1H). 
13C NMR (126 MHz, D2O, pD 8) δ =  174.4 (assigned by 2D NMR), 60.0, 39.5, 16.0, 12.8, 3.9, 2.6. 
 
35 from D-cyclopropyalanine (27) and  13CH3I. 
HRESIMS C6H1413CNO2 (M+H)+, calcd. 145.1053, obsvd. 145.1055 
1H NMR (500 MHz, D2O, pD 8) δ =  3.64 (dd, J = 4.5, 3.6 Hz, 1H), 1.35 – 1.26 (m, 1H), 1.05 (dd, J = 
126.6, 7.0 Hz, 3H), 0.58 – 0.72 (m, 1H), 0.39 – 0.55 (m, 2H), 0.17 – 0.31 (m, 1H), 0.02 – 0.13 (m, 1H). 




36 from D-cyclopropyalanine (27) and CD3I. 
HRESIMS C7H11D3NO2 (M+H)+, calcd. 147.1208, obsvd. 147.1207 
1H NMR (500 MHz, D2O, pD 8) δ =  3.64 (d, J = 4.6 Hz, 1H), 1.28 (dd, J = 9.9, 4.7 Hz, 1H), 0.59 – 
0.70 (m, 1H), 0.41 – 0.53 (m, 2H), 0.17 – 0.25 (m, 1H), 0.09 (ddd, J = 9.2, 4.7, 1.5 Hz, 1H). 
13C NMR (126 MHz, D2O, pD 8) δ =  174.4 (assigned by 2D NMR), 59.9, 39.2, 15.2 (CD3, assigned by 






Supplementary Figure 1. Representative natural products containing β-Me-α-aa and the biosynthetic pathway of those β-Me-






Supplementary Figure 2. SDS-PAGE of recombinant enzymes. lane 1. Marker with annotated MS (kD). lane 2. HMT, lane 

















Supplementary Figure 3. Conversion of IlvE-SgvM cascade taking L-norvaline (1) as substrate. β-H was choosen to 
calculate the conversion. Conversion = 0.52/(0.52 + 0.96/2) x 100% = 52%. 
 
Supplementary Figure 4. 1H NMR of compound 11 (top), authentic L-allo-isoleucine (middle) and L-isoleucine (bottom). 






Supplementary Figure 5. 3R:3S ratio of product of IlvE-SgvM cascade reaction using L-norvaline (1) as substrate. Ratio 








Supplementary Figure 6. Conversion of IlvE-SgvM cascade taking L-leucine (2) as substrate. Conversion was calculated 
based on integrals of α-H from both substrate and product. Conversion = 0.89/(0.11 + 0.89) x 100% = 89%. 
 
Supplementary Figure 7. 3R:3S ratio of product of IlvE-SgvM cascade reaction using L-leucine (2) as substrate. Ratio was 






Supplementary Figure 8. Conversion of IlvE-SgvM cascade taking L-norleucine (3) as substrate. Conversion was calculated 
based on integrals of α-H from both substrate and product. Signal of α-H from 3 was partially overlapping with that from 13. 
Conversion = (0.90 – 0.10) /(0.10 + 0.90) x 100% = 80 %. 
 
Supplementary Figure 9. 3R:3S ratio of product of IlvE-SgvM cascade reaction using L-norleucine (3) as substrate. Ratio 








Supplementary Figure 10. Conversion of IlvE-SgvM cascade taking L-allylglycine (4) as substrate. Conversion was 
calculated based on integrals of α-H from both substrate and product. Conversion = 0.83/(0.17 + 0.83) x 100% = 83 %. 
 
Supplementary Figure 11. 3R:3S ratio of product of IlvE-SgvM cascade reaction using L-allylglycine (4) as substrate. Ratio 








Supplementary Figure 12. Conversion of IlvE-SgvM cascade taking L-4,5-dehydroleucine (5) as substrate. Conversion was 
calculated based on integrals of α-H from both substrate and product. Conversion = 0.87/(0.13 + 0.87) x 100% = 87 %. 
 
Supplementary Figure 13. 3R:3S ratio of product of IlvE-SgvM cascade reaction using L-4,5-dehydroleucine (5) as 







Supplementary Figure 14. Conversion of IlvE-SgvM cascade taking L-2-amino-5-methyl hexanoic acid (6) as substrate. 
Conversion was calculated based on integrals of ε-H from both substrate and product. Conversion = 0.82/(0.18 + 0.82) x 
100% = 82%. 
 
Supplementary Figure 15. 3R:3S ratio of product of IlvE-SgvM cascade reaction using L-2-amino-5-methyl hexanoic acid 








Supplementary Figure 16. Conversion of IlvE-SgvM cascade taking L-2-amino-5-methyl hexenoic acid (7) as substrate. 
Conversion was calculated based on integrals of allylic methyl groups from both substrate and product. Conversion = 2.11/(2.11 
+ 0.89) x 100% = 70 %. 
 
Supplementary Figure 17. 3R:3S ratio of product of IlvE-SgvM cascade reaction using L-2-amino-5-methyl hexenoic acid 







Supplementary Figure 18. Conversion of IlvE-SgvM cascade taking L-methionine (8) as substrate. Conversion was calculated 
based on integrals of methyl groups from both substrate and product. Conversion = 0.47/1.00 x 100% = 47%. 
 
Supplementary Figure 19. 3R:3S ratio of product of IlvE-SgvM cascade reaction using L-methionine (8) as substrate. Ratio 






Supplementary Figure 20. Conversion of IlvE-SgvM cascade taking L-cyclopropylalanine (9) as substrate. Conversion was 
calculated based on integrals of β-H from both substrate and product. Conversion = 0.96/(0.96 + 0.08/2) x 100% = 96 %. 
 
Supplementary Figure 21. 3R:3S ratio of product of IlvE-SgvM cascade reaction using L-cyclopropylalanine (9) as 







Supplementary Figure 22. Conversion of MarG-MarI cascade taking L-tryptophan (10) as substrate. Conversion was 
determined over 95 %, because no substrate was observed in reaction mixture (Top) while resonances was evidently observed 
in control experiment with 100 µM substrate (Bottom). Therefore, residue substrate within reaction mixture is lower than 100 
µM, corresponding to 95 % of conversion. 
 
Supplementary Figure 23. 3R:3S ratio of product of IlvE-SgvM cascade reaction using L-tryptophan (10) as substrate. 








Supplementary Figure 24. Conversion of D-TA-SgvM cascade taking D-norvaline (21) as substrate Conversion was 
calculated based on integrals of α-H from both substrate and product. Conversion = 0.50/(0.50 +0.50) x 100% = 50 % 
 
Supplementary Figure 25. 3R:3S ratio of product of D-TA-SgvM cascade reaction using D-norvaline (21) as substrate. No 









Supplementary Figure 26. Conversion of D-TA-SgvM cascade taking D-leucine (22) as substrate Conversion was 
calculated based on integrals of α-H from both substrate and product. Conversion = 0.39/(0.39 +0.61) x 100% = 39 % 
 
Supplementary Figure 27. 3R:3S ratio of product of D-TA-SgvM cascade reaction using D-leucine (22) as substrate. Ratio 







Supplementary Figure 28. Conversion of D-TA-SgvM cascade taking D-norleucine (23) as substrate Conversion was 
calculated based on integrals of α-H from both substrate and product. Conversion = 0.90/(0.9 +0.10) x 100% = 90 % 
 
Supplementary Figure 29. 3R:3S ratio of product of D-TA-SgvM cascade reaction using D-norleucine (23) as substrate. 










Supplementary Figure 30. Conversion of D-TA-SgvM cascade taking D-allylglycine (24). Conversion was determined over 
95 %, because no substrate was observed in reaction mixture (Top) while resonances was evidently observed in control 
experiment with 100 µM substrate (Bottom). Therefore, residue substrate within reaction mixture is lower than 100 µM, 
corresponding to 95 % of conversion. 
 
Supplementary Figure 31. 3R:3S ratio of product of D-TA-SgvM cascade reaction using D-allylglycine (24) as substrate. 










Supplementary Figure 32. Conversion of D-TA-SgvM cascade taking D-2-amino-5-methyl hexanoic acid (25) as substrate 
Conversion was calculated based on integrals of α-H from both substrate and product. Conversion = 0.89/(0.89 +0.11) x 100% 
= 89 % 
 
Supplementary Figure 33. 3R:3S ratio of product of D-TA-SgvM cascade reaction using D-2-amino-5-methyl hexanoic 









Supplementary Figure 34. Conversion of D-TA-SgvM cascade taking D-methionine (26) as substrate Conversion was 
calculated based on integrals of S- and β-methyl groups from both substrate and product. Conversion = 2.44/3 x 100% = 81 
% 
 
Supplementary Figure 35. 3R:3S ratio of product of D-TA-SgvM cascade reaction using D-methionine (26) as substrate. 








Supplementary Figure 36. Conversion of D-TA-SgvM cascade taking D-cyclopropylalanine (27) as substrate. Conversion 
was determined over 95 %, because no substrate was observed in reaction mixture (Top) while resonances was evidently 
observed in control experiment with 100 µM substrate (Bottom). Therefore, residue substrate within reaction mixture is lower 
than 100 µM, corresponding to 5 % of starting concentration. 
Supplementary Figure 37. 3R:3S ratio of product of D-TA-SgvM cascade reaction using D-cyclopropylalanine (27) as 








Supplementary Figure 38. Conversion of D-TA-SgvM cascade taking D-cyclopropylalanine (27) as substrate and 13C-
iodomethane. Conversion was determined over 95 %, because no substrate was observed in reaction mixture (Top) while 
resonances was evidently observed in control experiment with 100 µM substrate (Bottom). Therefore, residue substrate within 
reaction mixture is lower than 100 µM, corresponding to 5 % of starting concentration. 
 
Supplementary Figure 39. 3R:3S ratio of product of D-TA-SgvM cascade reaction using D-cyclopropylalanine (27) and 








Supplementary Figure 40. Conversion of D-TA-SgvM cascade taking D-cyclopropylalanine (27) as substrate and 
iodomethane-d3. Conversion was determined over 95 %, because no substrate was observed in reaction mixture (Top) while 
resonances was evidently observed in control experiment with 100 µM substrate (Bottom). Therefore, residue substrate within 
reaction mixture is lower than 100 µM, corresponding to 5 % of starting concentration. 
 
Supplementary Figure 41. 3R:3S ratio of product of D-TA-SgvM cascade reaction using D-cyclopropylalanine (27) and 










Origin of stereochemical heterogeneity in enzyme-catalyzed production of β-Me-a-aas   
The minor stereochemical heterogeneity in the methylated product could occur because of limited 
stereoselectivity of the involved enzymes or uncatalyzed racemization. In our previous report on SgvM-
catalyzed methylation of alpha-keto acids we showed that uncatalyzed racemization at C3 occurs at an 
appreciable rate (3 x 10−7 s−1),1 whereas SgvM-catalyzed methyl transfer occurs with nearly absolute 
selectivity. The diastereomeric ratio of the final product (β-Me-a-aa) is therefore a function of this rate 
and the steady state concentration of the methylated keto acid intermediate. The concentration of this 
intermediate is dependent on the concentration of PLP (bound to TA and unbound). Because the D-TA 
was less active than IlvE (L-TA) we used higher PLP and TA concentrations for the D-a-amino acid 
(described above). Therefore, it is not surprising that methylation of D-a-amino acid produced product 
with slightly smaller diastereomeric ratios. 
We also considered the possibility that limited stereoselectivity of the TAs could lead to the observed 
minor diastereomers. To test this idea, we fed the IlvE/SgvM/HMT cascade with D-a-amino acid 
(norvaline, leucine, norleucine, allylglycine) and examined the products by mass spectrometry. In 
contrast to reactions with L-a-amino acids we could not detect any product in the D-a-amino acid 
containing reactions (Figure S42). The complementary experiment with D-TA and L-a-amino acids 
produced equivalent results (Figure S43). These observations provide no evidence for stereochemical 
heterogeneity caused by L- or D-TAs. Hence, we conclude that the minor isomer in the produced β-Me-




The IlvE/SgvM/HMT cascade does not methylate D-a-amino acid. 0.1 ml reactions containing 2 
mM of L- or D-a-amino acids, 4 mM methyl iodide, 40 µM SAH, 40 µM PLP, 40 µM IlvE, 40 µM 
SgvM, 20 µM HMT and 100 mM sodium phosphate buffer (pH = 8.0) were incubated at room 
temperature. After 24 hours, 20 µL of the reaction mixture was dilute with 980 µL of methanol. After 
filtration with 0.45 µm syringe filter, the sample were analyzed by mass spectrometry. Extracted-ion 
chromatograms of these measurements show that L-a-amino acids were methylated, but D-a-amino 




Supplementary Figure 42. Extracted ion chromatogram (EIC) of IlvE cascades accepting L- or D-a-amino acids. Substrates 
were indicated in each figure. It is shown that D-a-amino acids were not methylated by IlvE .  






































































The D-TA/SgvM/HMT cascade does not methylate L-a-amino acid. 
0.1 ml reactions containing 2 mM of L- or D-a-amino acids, 4 mM methyl iodide, 40 µM SAH, 80 µM 
PLP, 80 µM D-TA, 40 µM SgvM, 20 µM HMT and 100 mM sodium phosphate buffer (pH = 8.0) were 
incubated at room temperature. After 24 hours, 20 µL of the reaction mixture was dilute with 980 µL of 
methanol. After filtration with 0.45 µm syringe filter, the sample were analyzed by mass spectrometry. 
Extracted-ion chromatograms of these measurements show that D-a-amino acids were methylated, but 




Supplementary Figure 43. Extracted ion chromatograms (EIC) of D-TA cascades accepting L- or D-a-amino acids. Substrates 
were indicated in each figure. It is shown that L-a-amino acids were not methylated by D-TA.  




























































































 D-2-amino-5-methyl hexanoic acid (25)
 L-2-amino-5-methyl hexanoic acid (5)
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